News 12 abr 2024 Carrier plans new regional innovation & technology center in Lucerne, Switzerland Carrier Global Corporation is planning a new innovation and technology centre in Lucerne. This strategic investment consolidates its position as ...
News 12 jun 2023 Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp Pharma giant Lonza is enhancing its capabilities in the development of novel cancer treatments through an investment of over CHF 97 million in Vi...
News 11 jan 2023 Bachem Group secures CHF 1 billion peptide supply contract Bachem Group's recent CHF 1 billion peptide supply deal, spanning over five years will enable the company's plans to expand capacity across all i...
Actualités 11 out 2023 Lonza élargit davantage ses capacités de fabrication d’ADC à Viège Lonza amplifie sa production d’ADC via une extension importante de la capacité de bioconjugaison de son Ibex Dedicate Biopark à Viège, ce qui dev...
News 18 out 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News 25 mar 2022 Basel Area sets new record for new company settlements For Basel Area Business & Innovation, 2021 was a record year. Last year, the investment and innovation promotion agency supported the settlement ...
News 30 set 2021 Basel Area becomes the Swiss hotspot for Chinese pharma companies More and more Chinese pharmaceutical companies are choosing the Basel Area as location for their subsidiary in Switzerland. Among them is Hengrui...
News 27 jun 2023 Gallus opens innovation center St.Gallen - The Gallus Group has opened a new innovation center to mark its centenary celebrations. This is designed as a focal point for custome...
News 08 out 2021 Ma Cher establishes European HQ in Switzerland “Lured by mountains and incredible pool of Swiss talent”, sustainability-driven creative branding company Ma Cher has recently opened its Europea...
News 13 abr 2021 Lonza to create 1,200 new jobs at its Covid-19 vaccine production site in Visp Biopharmaceutical giant Lonza has announced the creation of 1,200 new jobs for the manufacturing of Moderna’s Covid-19 vaccine on its site in Vis...
Global Opportunities 03 jun 2020 The Pharmaceutical Sector in Ireland: Opportunities for Swiss companies As cornerstones of the Irish economy, the pharma and life sciences sectors have contributed vastly to the attractiveness of Ireland to foreign co...
Инвестиции в Швейцарии Ваши контакты за рубежом Представительства S-GE за рубежом называются «Швейцарские Центры содействия бизнесу» (Swiss Business Hubs).
Globales Netzwerk Unsere Standorte weltweit Gemeinsam mit dem Eidgenössischen Departement für auswärtige Angelegenheiten (EDA) unterhalten wir derzeit Vertretungen in mehr als 25 ...
Réseau Mondial Nos antennes dans le monde En collaboration avec le Département fédéral des affaires étrangères (DFAE), nous entretenons actuellement des bureaux dans plus de 25 pays.